104 related articles for article (PubMed ID: 8489306)
1. [Clinical efficacy of YNK 01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) in patients with polycythemia vera].
Naito K; Kitaori K; Morishima Y
Gan To Kagaku Ryoho; 1993 May; 20(7):973-6. PubMed ID: 8489306
[No Abstract] [Full Text] [Related]
2. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Ueda T; Kamiya K; Urasaki Y; Wataya S; Kawai Y; Tsutani H; Sugiyama M; Nakamura T
Cancer Res; 1994 Jan; 54(1):109-13. PubMed ID: 8261429
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
Tatsumi N; Yamada K; Ohshima T; Nakamura T; Ohno R; Masaoka T; Kimura I; Kimura K
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
[TBL] [Abstract][Full Text] [Related]
4. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
Fukuoka M; Miyazaki T; Yoshida Y; Hattori M; Niitani H; Nakamura T; Hirota Y; Ohta K; Tanaka M; Suzuoki Y
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2213-9. PubMed ID: 2241185
[TBL] [Abstract][Full Text] [Related]
5. [Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
Suto T; Yoshida Y; Sakata Y; Ono T; Yoshida T; Yamada N; Chida N; Oohira H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1933-8. PubMed ID: 9797816
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of myelodysplastic syndrome with 1-beta-D-arabinofuranosylcytosine 5'-stearylphosphate.
Ueda T; Imamura S; Kawai Y; Wano Y; Kamiya K; Tsutani H; Nakamura T
Leuk Res; 1990; 14(11-12):1067-8. PubMed ID: 2280605
[No Abstract] [Full Text] [Related]
7. [Clinical effects of stearyl-ara-CMP (YNK-01) on chronic hematologic malignancies].
Im T; Ota K; Ohira H; Yasui Y; Nakao Y; Furukawa Y; Inoue K; Yamane T; Hiyoshi M; Kishida T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):139-42. PubMed ID: 1987896
[No Abstract] [Full Text] [Related]
8. Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate.
Ohno R; Tatsumi N; Hirano M; Imai K; Mizoguchi H; Nakamura T; Kosaka M; Takatsuki K; Yamaya T; Toyama K
Oncology; 1991; 48(6):451-5. PubMed ID: 1749580
[TBL] [Abstract][Full Text] [Related]
9. Characteristic antitumor activity of cytarabine ocfosfate against human colorectal adenocarcinoma xenografts in nude mice.
Koga K; Iizuka E; Sato A; Ekimoto H; Okada M
Cancer Chemother Pharmacol; 1995; 36(6):459-62. PubMed ID: 7554036
[TBL] [Abstract][Full Text] [Related]
10. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Nishikawa M; Morita K; Komada F; Uemura Y; Kageyama S; Minami N; Deguchi K; Shirakawa S
Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
[TBL] [Abstract][Full Text] [Related]
11. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
Yano K; Matsui H; Fujisawa S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):427-30. PubMed ID: 9492840
[No Abstract] [Full Text] [Related]
12. Combined oral administration of etoposide and arabinofuranosylcytosine-5'-stearylphosphate enhances the antitumor effect against P388 ascites tumors.
Higashigawa M; Cao DC; Matsui K; Yamada S; Kakitou H; Kagawa Y; Inamochi H; Ido M; Sakurai M
Cancer Chemother Pharmacol; 1994; 33(4):281-5. PubMed ID: 8281619
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.
Kodama K; Morozumi M; Saitoh K; Kuninaka A; Yoshino H; Saneyoshi M
Jpn J Cancer Res; 1989 Jul; 80(7):679-85. PubMed ID: 2507491
[TBL] [Abstract][Full Text] [Related]
14. The effect of YNK-01 (an oral prodrug of cytarabine) on hepatocellular carcinoma.
Suto T; Miyazawa J; Watanabe Y; Suto K; Yoshida Y; Sakata Y
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-122-S6-129. PubMed ID: 9151927
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate].
Arai T; Narimiya S; Hayakawa K; Takaya T; Toshima S; Araki M; Uchida A; Yoshimi N; Shibuya C; Yasuda Y
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1085-8. PubMed ID: 8002627
[No Abstract] [Full Text] [Related]
16. Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
Cervantes F; Sureda A; Hernández-Boluda JC; Martino R; Brunet S; Borrego D; Antich JL; Montserrat E
Haematologica; 2001 Dec; 86(12):1281-6. PubMed ID: 11726320
[TBL] [Abstract][Full Text] [Related]
17. [Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T].
Kadowaki I; Sasaki O; Sasaki T; Ishizawa K; Kimura J; Nomura J; Furuyama K; Harigae H; Shishido T; Okuda M
Gan To Kagaku Ryoho; 1995 Jan; 22(1):145-7. PubMed ID: 7529978
[No Abstract] [Full Text] [Related]
18. Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
Kühr T; Eisterer W; Apfelbeck U; Linkesch W; Bechter O; Zabernigg A; Geissler K; Barbieri G; Duba C; Gastl G; Thaler J
Leuk Res; 2000 Jul; 24(7):583-7. PubMed ID: 10867132
[TBL] [Abstract][Full Text] [Related]
19. A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog.
Ide K; Momoi Y; Minegishi M; Sekiguchi M; Konno K; Iwasaki T
Aust Vet J; 2003; 81(1-2):47-9. PubMed ID: 15084010
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of clinical usefulness of thiamphenicol in the management of patients with polycythemia vera].
Yamauchi H; Kurabayashi H; Katahira H; Sawamura M; Karasawa M; Yatabe H; Sugita Y; Nogiwa E; Iwata N; Omine M
Rinsho Ketsueki; 1986 Oct; 27(10):1843-9. PubMed ID: 3820609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
